Background. Patients hospitalized with influenza may require extended care on discharge. We aimed to explore predictors for extended care needs and the potential mitigating effect of antiviral treatment among communitydwelling adults aged ≥65 years hospitalized with influenza.
are therefore at high risk of further functional decline [3, 4] . However, functional decline caused by influenza-associated hospitalization among older adults living independently in the community has not been well documented. Serious illness or injury leading to hospitalization or restricted activity has been shown to precipitate disability in older adults, even among those not considered physically frail [4, 5] . Disability is often measured by the loss of independence in performing essential activities of daily living (ADLs), such as bathing, dressing, and walking. Disability is associated with increased risk of mortality and may result in nursing home placement or a greater use of formal or informal home care services.
Influenza vaccine in older adults has low to moderate effectiveness [6, 7] , and antiviral treatment may be an important adjunct in preventing severe influenza-related complications. Currently, antiviral treatment is recommended for those hospitalized with confirmed or suspected influenza or at high risk for complications [8] . Some studies have shown that prompt treatment with influenza antiviral agents can reduce the duration of illness and prevent influenza-related complications, including death, among hospitalized patients [9] [10] [11] [12] . However, data on the benefit of antiviral agents among older adults hospitalized with influenza are limited. We explored the effect of influenza-associated hospitalization and the potential mitigating impact of early treatment with influenza antiviral agents on hospital length of stay and disability, as measured by extended care needs at discharge, among community-dwelling adults aged ≥65 years.
METHODS

Study Setting and Population
We used data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), collected during the 2010-2011, 2011-2012, and 2012-2013 influenza seasons from 1 October through 30 April. FluSurv-NET conducts population-based hospitalization surveillance for influenza in approximately 80 selected counties located in California, Colorado, Connecticut, Georgia, Idaho, Iowa, Maryland, Michigan, Minnesota, New York, Oklahoma, Ohio, Oregon, Rhode Island, Tennessee, and Utah. Cases were prospectively identified based on review of hospital laboratory, infection control, and admission or discharge logs. Information on demographic characteristics, medical history, underlying conditions, clinical course, and treatment was collected for each case through review of medical charts, using a standardized questionnaire as described elsewhere [13] . Data on influenza vaccination status were verified using a vaccination registry or the patient's primary care provider. Influenza virus infection was laboratory-confirmed by real time-reverse-transcription polymerase chain reaction, viral culture, direct or indirect fluorescent antibody staining, or rapid antigen test; influenza testing was ordered at the discretion of attending clinicians. We analyzed data on community-dwelling adults aged ≥65 years admitted to the hospital with communityacquired influenza (ie, hospitalized ≤3 days from a positive influenza test).
Human Subjects Review
This data collection was determined by the Centers for Disease Control and Prevention's (CDC's) human subject expert to be for routine public health surveillance purposes, and thus was not subject to CDC institutional review board approval for human research protections. Participating sites submitted the study to their state and local institutional review boards for review as needed.
Definitions
Underlying conditions were organized in categories. We studied immunosuppressive conditions, neurologic disorders, cardiovascular diseases, chronic lung diseases, metabolic disorders, blood disorders, renal disease, and liver disease. The category of immunosuppressive condition included immunoglobulin deficiency, cancer, human immunodeficiency virus/AIDS, and treatment with oral or injectable steroids for a ≥2 weeks before admission. The category of neurologic disorders included paralysis, muscular dystrophies, myasthenia gravis, multiple sclerosis, dementia, and cognitive dysfunction. Cardiovascular diseases included conditions such as coronary heart disease, cardiac valve disorders, congestive heart failure, and pulmonary hypertension (isolated hypertension excluded). Chronic lung diseases included chronic obstructive pulmonary disease and interstitial lung disease. Metabolic disorders included diabetes mellitus, thyroid dysfunction, and adrenal insufficiency. Blood disorders included thalassemia, thrombocytopenia, and polycythemia vera. A patient could be reported with ≥1 comorbidity category.
Body mass index (BMI) was used to classify patients within weight categories as underweight (BMI, <18.5), normal weight (18.5 to <25), overweight (25 to <30), obese (30 to <40), or morbidly obese (≥40). Pneumonia at admission was defined by the presence of air space density/opacity, consolidation, lobar infiltrate, or pleural effusion in a chest radiograph obtained during the first 24 hours of hospital admission, combined with a discharge diagnosis of pneumonia.
We categorized timing of antiviral treatment as early (given ≤4 days after illness onset) or late (given >4 days after illness onset), based on the finding that antiviral treatment may not affect course of illness if given >4-5 days after illness onset [12, 14, 15] . Extended care was defined as new placement in a skilled nursing home/long-term care facility or rehabilitation facility at hospital discharge. Patients transferred to other hospitals during hospitalization were excluded from the analysis.
Statistical Analysis
Demographic and clinical characteristics were described according to extended care needs at hospital discharge. The association between categorical variables was assessed using χ 2 test (or Fisher exact test when appropriate), and Kruskal-Wallis tests were used for continuous variables. We used logistic regression to explore risk factors for and the impact of antiviral treatment on extended care needs on discharge. Variables known as potential confounders and/or associated with extended care in the univariate analysis (P < .1) were included in the multivariable models; variables that changed the odds ratio for outcomes of interest by ≥10% when removed were retained in the model. We also used competing risk survival analysis model based on Fine and Gray [16] to assess whether patients treated early with antivirals had an increased probability of being discharged from hospital sooner than those treated late (>4 days from illness onset), using death as a competing event and adjusting for potential confounders. Kaplan-Meier cumulative incidence curves were derived.
For both the logistic regression and competing risk survival models, we decided to show the models separately for those hospitalized early in the course of illness (≤2 days from illness onset) versus late (>2 days), because of collinearity between time from illness onset to treatment and time from illness onset to hospitalization. We also limited these analysis to patients treated with antiviral agents. We were concerned about potential treatment indication bias, because treated patients were different from untreated ones. Treated patients (n = 5741) were older than untreated patients (n = 1229), more frequently white, more likely to be vaccinated against influenza, more often admitted to the intensive care unit (ICU), and had a longer hospitalization. Furthermore, those not treated with antiviral agents had a longer interval between onset of illness and hospital admission than those treated (median [interquartile range], 3 [2] [3] [4] [5] vs 2 [1-4] days; P < .001). Data analysis was performed using SAS (version 9.3; SAS Institute) and R (version 3.0.2) software.
RESULTS
Characteristics by Extended Care Needs at Hospital Discharge
During the 2010-2011, 2011-2012, and 2012-2013 influenza seasons, 9059 influenza-associated hospitalizations were reported among adults aged ≥65 years. To look at extended care needed on discharge, we excluded 2215 cases who were living in institutions (not community dwellers) before hospitalization, 192 who died during hospitalization, 30 who were transferred to other hospitals, and 29 whose disposition at hospital discharge was unknown. Of the remaining 6593 communitydwelling adults aged ≥65 years with laboratory-confirmed influenza, 1184 (18%) patients required new placement at a skilled nursing/long-term care, or rehabilitation facility on hospital discharge.
In our univariate analysis, extended care among those previously living in the community was associated with increasing age: 10% (230) among those aged 65-74 years, 16% (407) among those aged 75-84 years, and 30% (547) among those aged ≥85 years (P < .001) ( Table 1) . Extended care was also associated with white non-Hispanic race, presence of underlying chronic medical conditions, low BMI, and receipt of influenza vaccination and antiviral treatment. The prevalence of specified chronic medical conditions was fairly evenly distributed among those who did and those who did not require extended care, with the exception of the presence of cardiovascular disease (61% vs 54%; P < .001), and neurologic disorders (18% vs 9%; P < .001), both associated with the need for extended care. Most influenza hospitalizations were associated with influenza A virus infections, reflecting the dominant influenza virus type in circulation during the surveillance period. However, patients with influenza A virus infection required extended care slightly more often than those with influenza B (18% vs 16%; P = .04). In >50% of influenza A cases, the viral subtype was unavailable. The proportion of patients discharged to extended care varied significantly by surveillance site and ranged from 12% to 27%.
Patients who required extended care at discharge were more likely to have experienced influenza-related complications than those discharged to home. The frequency of communityacquired pneumonia (35% vs 26%), encephalitis (4% vs 1%), ICU admission (25% vs 10%), mechanical ventilation (11% vs 2%), and hospitalization >5 days (72% vs 29%) were all significantly higher among those requiring extended care than among those patients discharged to home (Table 2) .
Treatment with Influenza Antiviral Drugs
Among all 5741 patients with history of antiviral treatment (including 142 who died), we excluded 290 that had no date of treatment, and 149 who started treatment >2 days before hospital admission. Among the remaining 5302 treated patients, 76% received antivirals early in the course of illness (Figure 1 ). The time from illness onset to hospital admission was a median (interquartile range) of 1 (1-2) day for those treated early and 4 (3-7) days for those treated late (P < .01; Kruskal-Wallis test).
Risk Factors and Effect of Antiviral Treatment on Extended Care (Logistic Regression Analysis)
Among 3110 treated patients admitted ≤2 days after illness onset, our logistic regression model included age group, race/ethnicity, cardiovascular disease, neurologic disorder, timing of antiviral treatment (early vs late), ICU admission, BMI categories, receipt of influenza vaccination for the season, influenza virus type, influenza season, and study site. Community-acquired pneumonia was used as a measure of severity at admission. We did not add mechanical ventilation or length of hospital stay to the model; these variables were highly correlated with being admitted to Figure 2 ). Patients with neurologic disorders (aOR, 2.05; 95% CI, 1.50-2.80), and those admitted to the ICU during the course of hospitalization (3.27; 2.41-4.42) were more likely to require extended care on discharge. Patients with pneumonia at admission were also more likely to require extended care (aOR 1.52; 95% CI, 1.18-1.95). The odds of requiring extended care were significantly associated with study site, being higher in Connecticut, Maryland, and Minnesota compared with Rhode Island (Supplementary Table 1) .
Among 2436 treated patients admitted >2 days after illness onset, our logistic regression model included the same covariates as described in the model above. After exclusions of missing values, we used a total of 1976 (81%) observations; 328 (16%) patients required extended care after discharge. The model showed similar independent risk factors for extended care needs (older age, presence of neuromuscular disorder, and ICU admission), all with comparable magnitudes of association ( Figure 2 ; Supplementary Table 1) . Early treatment still provided protection from extended care needs (aOR, 0.75; 95% CI, .56 -.97; P = .03)
Effect of Antiviral Treatment on Length of Hospital Stay (Competing Risk Survival Analysis)
Patients treated early were more likely to be discharged earlier than those who had antiviral treatment initiated later in the course of illness (ie, >4 days after illness onset). This was true for patients hospitalized soon after illness onset (≤2 days), Table 2 (1) 37 (1) 21 (2) ICU admission 847 (13) 546 (10) 301 (25) Mechanical ventilation 252 (4) 120 (2) 132 (11 with an adjusted hazard ratio of 1.8 (95% CI, 1.43-2.30; P <.01), and for those hospitalized >2 days after illness onset (adjusted hazard ratio, 1.30; 95% CI, 1.20-1.40; P <.01). Both models were adjusted for age categories, presence of underlying chronic medical conditions, pneumonia diagnosed at admission and influenza season. The cumulative incidence function for hospital discharge by timing of treatment for those hospitalized ≤2 or >2 days after illness onset can be seen in Figure 3A and 3B respectively; in both, death was considered a competing risk.
DISCUSSION
In our analysis, 18% of community-dwelling adults aged ≥65 years required extended care after influenza-associated hospitalization. Extended care needs increased with age, with almost 1 in every 3 adults aged ≥85 years requiring new placement in skilled nursing homes or rehabilitation facilities after influenza hospitalization. Older age, the presence of neurologic disorders, ICU admission, and pneumonia at admission were all independent risk factors for extended care needs. Early treatment with antiviral agents significantly reduced the odds of requiring extended care at discharge compared with later treatment, and it reduced the length of hospitalization.
To our knowledge, our study is the first to look at the benefit of antiviral treatment on preventing the need for extended care after influenza hospitalization in older adults living in the community. This benefit could be explained by the reduced length of stay among patients treated early in the course of illness, because lengthy restriction to bed can precipitate disability [4, 5] . A few studies have shown the benefit in duration and severity of illness of starting antiviral treatment even after 48 hours of illness onset [10, [12] [13] [14] [15] 17] . Lee et al [12] showed that oseltamivir treatment started within 4 days of illness onset among hospitalized, severely ill patients with influenza was associated with viral clearance and improved survival; these patients have prolonged viral replication, thus widening the window of opportunity to initiate antiviral treatment [12, 14, 15, 17, 18] . Time from illness onset to hospitalization could be associated with disease severity, but in our study we documented the benefit of early antiviral treatment (≤4 days after illness onset) among those hospitalized early in the course of illness and those hospitalized late (>2 days after onset). Nonetheless, many older adults with respiratory infection delay seeking care, missing the opportunity for early therapeutic interventions that could halt life-threatening outcomes, principally among those suffering from comorbid conditions.
To our knowledge, only 1 other study has attempted to quantify the effect of influenza in those ≥65 years based on specialized care needed after influenza-associated hospitalization. Falsey et al [19] described influenza-associated hospitalization among 210 patients aged ≥65 years during 1989-1992 and found that among those who were living independently at home before admission and who survived hospitalization, 10% required extended care at discharge. This rate is somewhat lower than what we found in our analysis and may be partially explained by changes in hospital policy toward discharging patients early to acute care facilities. Increased care needs after influenza hospitalization may result from worsening of existing disabilities or development of new ones.
The presence of a neurologic disorder was also associated with extended care needs. Complications such as pneumonia are more likely among patients with muscle weakness and may lead to more medical monitoring and treatment requirements. We also found that admission to the ICU during hospitalization increased the odds of extended care needs by approximately 3-fold. Jeitziner et al [20] reported that among older adults surviving ICU admission, a decline in physical functional status (measured by ADLs) was observed, and patients were likely to require assistance in perform such tasks as using public transportation, shopping, and doing laundry. Moreover, ICU survivors have documented worsening cognitive functions which could also explain the need for extended care at hospital discharge [21] .
Our study has a number of limitations. Treatment day and influenza testing were not randomly allocated, and unmeasured differences in patient's characteristics that correlate with testing and treatment day could contribute to observed effect. Nonetheless, we had participation of >250 surveillance hospitals from 13 states across the United States, which probably dilutes any bias effect on differences in testing and treatment; we also controlled for site effects on our multivariate models. We did not directly measure ADLs in our study population, but it is likely that the need for extended care observed after hospitalization was due in part to impairment of functional status affecting the patient's ability to live independently. Information regarding the functional status of the patients living at home before the influenza hospitalization was not collected, but the fact that they were living at home in the community suggests a degree of independence and well-being. Assessment of changes in Figure 3 . A, Cumulative incidence function for hospital discharge patients hospitalized ≤2 days from illness onset. B, Hospitalized >2 days from illness onset, comparing patients treated early (≤4 days after illness onset) with those treated late (>4 days after illness onset), with death considered a competing risk (Influenza Hospitalization Surveillance Network, 2010-2013).
functional status and level of care needs after influenza hospitalization should be considered in future research.
CONCLUSIONS
A substantial proportion of older adults hospitalized with influenza require extended care after discharge. Antiviral treatment for all hospitalized patients with suspected or confirmed influenza is recommended [8] , and is particularly important among older adults. These patients should be oriented to seek care early in the course of their illness to fully benefit from therapeutic interventions. Our study suggests that antiviral treatment initiated ≤4 days after illness onset could lessen the overall impact of influenza and should be emphasized during influenza seasons as an important adjunct to influenza vaccination efforts.
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